on activation of smooth muscle [11] , suggesting that calyculin A more easily penetrates the pancreatic f3 cells than okadaic acid. Alternatively the inhibition of insulin release by these toxins may be due to inhibition of protein phosphatases-1, as reported in smooth muscle fibers where calyculin A was a more effective inhibitor than okadaic acid with protein phosphatases-1 [6] .
In the regulation of insulin release, increases in cytosolic levels of second messengers such as Ca2+, cAMP and diacylglycerol are thought to lead to insulin release via protein kinases [3] . If okadaic acid and calyculin A acted on only protein phosphatases which dephosphorylate substrates phosphorylated by these protein kinases, they would potentiate glucose-induced insulin release by increasing the phosphorylation state as they inhibited the myosin light chain phosphatase and enhanced tension development in smooth muscle fibers [9, 11] . Our experiments show this is not the case. Thus these toxins inhibited insulin release induced by glucose, which is known to increase cytosolic levels of the three second messengers [2] . The potentiation of glucose-induced insulin release by forskolin and high K+ was inhibited by okadaic acid. Moreover the effects of TPA, and high K+ on insulin release at a non-stimulatory concentration of 3 mM glucose were not potentiated by okadaic acid. However it cannot be ruled out the possibility that the toxins may act on protein phosphatases related to the three second messengers in addition to the other protein phosphatases and that the mixed actions on the pancreatic islets result in inhibition of insulin release. In accord with the present results, okadaic acid was reported to inhibit high K+-induced contraction without changing intracellular Ca2+ level in the arterial smooth muscle and suggested to decrease the sensitivity of contractile element to Ca2+ [12] .
Okadaic acid inhibited insulin release induced by glucose and glyceraldehyde dose-dependently. 
